Stay updated on Semaglutide Efficacy in Diabetes & Obesity Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page.

Latest updates to the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe updates include minor UI/text changes: a 'Show glossary' option is added, and labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' get capitalization updates. The revision/version is updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page now reflects a new revision, with v3.3.4 added and v3.3.3 removed.SummaryDifference0.0%

- Check46 days agoChange DetectedLocations section updated with numerous new trial sites across the US, Canada, India, and other regions, and several existing sites removed; revision is labeled v3.3.3.SummaryDifference2%

- Check67 days agoChange DetectedThe page shows a revision label updated from v3.3.1 to v3.3.2. There appear to be no visible changes to the study content beyond the version label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedThe Publications section adds two explanatory lines about voluntary publication submissions and automatic PubMed sourcing, and the Revision tag is updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check82 days agoChange DetectedRemoved the government funding status banner from the page, eliminating a banner that previously noted potential delays in updates due to funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Efficacy in Diabetes & Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page.